285 related articles for article (PubMed ID: 17224539)
1. Effect of health care delivery models on melanoma thickness and stage in a university-based referral center: an observational pilot study.
Swetter SM; Soon S; Harrington CR; Chen SC
Arch Dermatol; 2007 Jan; 143(1):30-6. PubMed ID: 17224539
[TBL] [Abstract][Full Text] [Related]
2. The relationship between melanoma thickness and time to diagnosis in a large population-based study.
Baade PD; English DR; Youl PH; McPherson M; Elwood JM; Aitken JF
Arch Dermatol; 2006 Nov; 142(11):1422-7. PubMed ID: 17116832
[TBL] [Abstract][Full Text] [Related]
3. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France.
Grange F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A
Arch Dermatol; 2008 May; 144(5):629-36. PubMed ID: 18490589
[TBL] [Abstract][Full Text] [Related]
4. The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in France.
Durbec F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Domissy-Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A; Grange F
Arch Dermatol; 2010 Mar; 146(3):240-6. PubMed ID: 20231493
[TBL] [Abstract][Full Text] [Related]
5. The Royal Flying Doctor Service primary care skin cancer clinic: a pilot program for remote Australia.
Scrace M; Margolis SA
Rural Remote Health; 2009; 9(1):1048. PubMed ID: 19239334
[TBL] [Abstract][Full Text] [Related]
6. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist.
Pennie ML; Soon SL; Risser JB; Veledar E; Culler SD; Chen SC
Arch Dermatol; 2007 Apr; 143(4):488-94. PubMed ID: 17438181
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy and early-stage melanoma.
Daryanani D; Plukker JT; De Hullu JA; Kuiper H; Nap RE; Hoekstra HJ
Cancer; 2003 May; 97(9):2248-53. PubMed ID: 12712479
[TBL] [Abstract][Full Text] [Related]
8. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
9. The association of Medicare health care delivery systems with stage at diagnosis and survival for patients with melanoma.
Kirsner RS; Wilkinson JD; Ma F; Pacheco H; Federman DG
Arch Dermatol; 2005 Jun; 141(6):753-7. PubMed ID: 15967922
[TBL] [Abstract][Full Text] [Related]
10. Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness.
Swetter SM; Johnson TM; Miller DR; Layton CJ; Brooks KR; Geller AC
Arch Dermatol; 2009 Apr; 145(4):397-404. PubMed ID: 19380661
[TBL] [Abstract][Full Text] [Related]
11. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
Fisher NM; Schaffer JV; Berwick M; Bolognia JL
J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
13. The performance of SolarScan: an automated dermoscopy image analysis instrument for the diagnosis of primary melanoma.
Menzies SW; Bischof L; Talbot H; Gutenev A; Avramidis M; Wong L; Lo SK; Mackellar G; Skladnev V; McCarthy W; Kelly J; Cranney B; Lye P; Rabinovitz H; Oliviero M; Blum A; Varol A; De'Ambrosis B; McCleod R; Koga H; Grin C; Braun R; Johr R
Arch Dermatol; 2005 Nov; 141(11):1388-96. PubMed ID: 16301386
[TBL] [Abstract][Full Text] [Related]
14. The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma: experience of an Australian tertiary referral service.
Ng JC; Swain S; Dowling JP; Wolfe R; Simpson P; Kelly JW
Arch Dermatol; 2010 Mar; 146(3):234-9. PubMed ID: 20231492
[TBL] [Abstract][Full Text] [Related]
15. Symptoms and signs of primary melanoma: important indicators of Breslow depth.
Negin BP; Riedel E; Oliveria SA; Berwick M; Coit DG; Brady MS
Cancer; 2003 Jul; 98(2):344-8. PubMed ID: 12872355
[TBL] [Abstract][Full Text] [Related]
16. Use of an early-detection strategy to improve disease control in melanoma patients.
Pacifico MD; Grover R; Sanders R
Br J Plast Surg; 2004 Mar; 57(2):105-11. PubMed ID: 15037164
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous melanoma in a multiethnic population: is this a different disease?
Hemmings DE; Johnson DS; Tominaga GT; Wong JH
Arch Surg; 2004 Sep; 139(9):968-72; discussion 972-73. PubMed ID: 15381614
[TBL] [Abstract][Full Text] [Related]
18. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
Risser J; Pressley Z; Veledar E; Washington C; Chen SC
J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
[TBL] [Abstract][Full Text] [Related]
19. Malignant melanoma in pregnancy. A population-based evaluation.
O'Meara AT; Cress R; Xing G; Danielsen B; Smith LH
Cancer; 2005 Mar; 103(6):1217-26. PubMed ID: 15712209
[TBL] [Abstract][Full Text] [Related]
20. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma.
Uliasz A; Lebwohl M
Int J Dermatol; 2007 Jun; 46(6):575-7. PubMed ID: 17550554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]